
Jupiter Life Line (JLHL) | Stock Overview & Key Data
Jupiter Life Line Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,770.00 on March 24, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Jupiter Life Line JLHL | 99.32B Mid-cap | -1.76% | 3.17% | -0.45% | -4.81% | -3.03% | 3.59% | 39.48% | 39.48% |
Max Healthcare MAXHEALTH | 1.05T Large-cap | -4.82% | -7.99% | -17.84% | -4.65% | -6.18% | 15.42% | 157.02% | 865.85% |
Apollo Hospitals APOLLOHOSP | 1.08T Large-cap | -0.81% | -3.70% | -1.53% | 11.66% | 1.08% | 9.98% | 69.53% | 227.15% |
Rainbow Children's RAINBOW | 137.65B Mid-cap | -0.56% | -10.31% | -14.62% | -1.42% | -12.89% | -1.81% | 98.29% | 210.21% |
Healthcare Global HCG | 91.91B Mid-cap | -0.53% | -7.24% | 17.65% | 20.69% | 32.78% | 49.75% | 112.65% | 433.55% |
Yatharth Hospital YATHARTH | 71.83B Mid-cap | -4.65% | -0.62% | 31.89% | 59.72% | 28.64% | 34.85% | 125.62% | 125.62% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is JLHL's 52-week high and low?
- In the last 52 weeks, Jupiter Life Line reached a high of ₹1,770.00 (on March 25, 2025) and a low of ₹1,266.00 (on April 7, 2025).
- What is the market cap and P/E ratio for JLHL?
- Curious about Jupiter Life Line's size and valuation? Its market capitalization stands at 99.32B. When it comes to valuation, the P/E ratio (trailing twelve months) is 51.28, and the forward P/E (looking ahead) is 38.97.
- Does JLHL pay dividends? If so, what's the yield?
- Yes, Jupiter Life Line is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.13%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Jupiter Life Line's main competitors or similar companies to consider before investing?
When looking at Jupiter Life Line, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Max Healthcare
MAXHEALTH1.05T Healthcare Medical Care Facilities 15.42% 157.02% Apollo Hospitals
APOLLOHOSP1.08T Healthcare Medical Care Facilities 9.98% 69.53% Rainbow Children's
RAINBOW137.65B Healthcare Medical Care Facilities -1.81% 98.29% Healthcare Global
HCG91.91B Healthcare Medical Care Facilities 49.75% 112.65% Yatharth Hospital
YATHARTH71.83B Healthcare Medical Care Facilities 34.85% 125.62% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Jupiter Life Line Hospitals Limited? (e.g., ROE, Debt/Equity)
- To get a sense of Jupiter Life Line's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.27%, the Debt to Equity ratio from the most recent quarter is 28.99, and its Gross Profit Margin stands at 80.33%.
- What is the recent revenue and earnings growth for JLHL?
- Looking at Jupiter Life Line's growth, its revenue over the trailing twelve months (TTM) was INR13B. Compared to the same quarter last year (YoY), quarterly revenue grew by 21.10%, and quarterly earnings saw a YoY growth of -1.70%.
- How much of JLHL stock is held by insiders and institutions?
- Wondering who owns Jupiter Life Line stock? Company insiders (like executives and directors) hold about 66.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 19.69%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.